| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.55B | -29.5% |
| Cost of Revenue | $16.80B | -35.3% |
| R&D Expense | $866.0M | -29.9% |
| SG&A Expense | $1.75B | -28.3% |
| Interest Expense | $734.0M | +23.2% |
| Pre-tax Income | $2.68B | +35.5% |
| Income Tax | $747.0M | +118.4% |
| Net Income | $2.03B | +17.8% |
| EPS (Basic) | $1.50 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.38B | -27.1% |
| Inventory | $4.81B | -33.4% |
| Total Assets | $39.38B | -20.3% |
| Total Liabilities | $32.41B | -23.9% |
| Stockholders' Equity | $6.93B | +1.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $557.0M | -86.4% |
| Investing Cash Flow | -$3.01B | +39.8% |
| Financing Cash Flow | $1.96B | +235.9% |
| +18.1% |
| EPS (Diluted) | $1.49 | +17.3% |